Loading...
Block of Voltage-Gated Sodium Channels by Atomoxetine in a State- and Use-dependent Manner
Atomoxetine, a neuroactive drug, is approved for the treatment of attention-deficit/hyperactivity disorder (ADHD). It is primarily known as a high affinity blocker of the noradrenaline transporter, whereby its application leads to an increased level of the corresponding neurotransmitter in different...
Saved in:
| Published in: | Front Pharmacol |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Frontiers Media S.A.
2021
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7959846/ https://ncbi.nlm.nih.gov/pubmed/33732157 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2021.622489 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|